Treatment of hyperhomocysteinemia with folic acid and vitamins B12 and B6 attenuates thrombin generation. (Q51560287)

7 April 2018

title

Treatment of hyperhomocysteinemia with folic acid and vitamins B12 and B6 attenuates thrombin generation. (English)

1 reference

7 April 2018

0 references

0 references

1 reference

4

Szczeklik A

1 reference

7 April 2018

1

Undas A

1 reference

7 April 2018

author name string

Domagala TB

series ordinal

2

1 reference

7 April 2018

Jankowski M

series ordinal

3

1 reference

7 April 2018

publication date

1 September 1999

1 reference

7 April 2018

published in

Thrombosis Research

1 reference

7 April 2018

volume

95

1 reference

7 April 2018

issue

6

1 reference

7 April 2018

page(s)

281-288

1 reference

7 April 2018

Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

Plasma homocyst(e)ine levels in men with premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

Hyperhomocysteinemia: an independent risk factor for vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

Putative mechanisms for vascular damage by homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

Homocysteine and atherothrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

Hyperhomocysteinemia following oral methionine load is associated with increased lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

Folate and Vitamin B 6 From Diet and Supplements in Relation to Risk of Coronary Heart Disease Among Women

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

Inhibition of thrombin generation by aspirin is blunted in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

Persistent generation of thrombin after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

The microcirculation in coronary ischemia. Are native anticoagulant mechanisms a path to new therapies?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

Blood coagulation changes in homocystinuria: effects of pyridoxine and other specific therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

Diet-responsive proconvertin (factor VII) deficiency in homocystinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

Homocystinemia. Vascular injury and arterial thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

Biological chemistry of thiols in the vasculature and in vascular-related disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900043-2

7 January 2021

10.1016/S0049-3848(99)00043-2

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018